Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Automated outreach to increase primary adherence to cholesterol-lowering medications.

Derose SF, Green K, Marrett E, Tunceli K, Cheetham TC, Chiu VY, Harrison TN, Reynolds K, Vansomphone SS, Scott RD.

JAMA Intern Med. 2013 Jan 14;173(1):38-43. doi: 10.1001/2013.jamainternmed.717.

PMID:
23403978
2.

Chipping away: improving primary medication adherence.

Fischer MA.

JAMA Intern Med. 2013 Jan 14;173(1):44-5. doi: 10.1001/jamainternmed.2013.1821. No abstract available.

PMID:
23183843
3.

Primary nonadherence to statin therapy: patients' perceptions.

Harrison TN, Derose SF, Cheetham TC, Chiu V, Vansomphone SS, Green K, Tunceli K, Scott RD, Marrett E, Reynolds K.

Am J Manag Care. 2013 Apr 1;19(4):e133-9.

4.

Primary nonadherence to statin medications in a managed care organization.

Cheetham TC, Niu F, Green K, Scott RD, Derose SF, Vansomphone SS, Shin J, Tunceli K, Reynolds K.

J Manag Care Pharm. 2013 Jun;19(5):367-73.

5.

Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.

Corrao G, Conti V, Merlino L, Catapano AL, Mancia G.

Clin Ther. 2010 Feb;32(2):300-10. doi: 10.1016/j.clinthera.2010.02.004.

PMID:
20206788
6.

Nonadherence to statin therapy: discontinuation after a single fill.

Lemstra M, Blackburn D.

Can J Cardiol. 2012 Sep-Oct;28(5):567-73. doi: 10.1016/j.cjca.2012.03.018. Epub 2012 May 31.

PMID:
22658124
7.

Alcohol screening scores and medication nonadherence.

Bryson CL, Au DH, Sun H, Williams EC, Kivlahan DR, Bradley KA.

Ann Intern Med. 2008 Dec 2;149(11):795-804.

PMID:
19047026
8.
9.
10.

Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial.

Calvert SB, Kramer JM, Anstrom KJ, Kaltenbach LA, Stafford JA, Allen LaPointe NM.

Am Heart J. 2012 Apr;163(4):657-65.e1. doi: 10.1016/j.ahj.2012.01.019.

PMID:
22520532
11.

Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis.

Lemstra M, Blackburn D, Crawley A, Fung R.

Can J Cardiol. 2012 Sep-Oct;28(5):574-80. doi: 10.1016/j.cjca.2012.05.007. Epub 2012 Aug 10. Review.

PMID:
22884278
12.

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.

13.

Pharmacist-to-prescriber intervention to close therapeutic gaps for statin use in patients with diabetes: A randomized controlled trial.

Renner HM, Hollar A, Stolpe SF, Marciniak MW.

J Am Pharm Assoc (2003). 2017 May - Jun;57(3S):S236-S242.e1. doi: 10.1016/j.japh.2017.04.009.

PMID:
28506378
14.

Pharmacy-based interventions to reduce primary medication nonadherence to cardiovascular medications.

Fischer MA, Choudhry NK, Bykov K, Brill G, Bopp G, Wurst AM, Shrank WH.

Med Care. 2014 Dec;52(12):1050-4. doi: 10.1097/MLR.0000000000000247.

15.

Effect of statin adherence on cerebrovascular disease in primary prevention.

Perreault S, Ellia L, Dragomir A, Côté R, Blais L, Bérard A, Lalonde L.

Am J Med. 2009 Jul;122(7):647-55. doi: 10.1016/j.amjmed.2009.01.032.

PMID:
19559167
16.

Physician-prompting statin therapy intervention improves outcomes in patients with coronary heart disease.

Hilleman DE, Monaghan MS, Ashby CL, Mashni JE, Woolley K, Amato CM.

Pharmacotherapy. 2001 Nov;21(11):1415-21.

PMID:
11714215
18.

An evaluation of educational outreach to improve evidence-based prescribing in Medicaid: a cautionary tale.

Zillich AJ, Ackermann RT, Stump TE, Ambuehl RJ, Downs SM, Holmes AM, Katz B, Inui TS.

J Eval Clin Pract. 2008 Oct;14(5):854-60. doi: 10.1111/j.1365-2753.2008.01035.x.

PMID:
19018918
19.

Suboptimal statin adherence and discontinuation in primary and secondary prevention populations.

Ellis JJ, Erickson SR, Stevenson JG, Bernstein SJ, Stiles RA, Fendrick AM.

J Gen Intern Med. 2004 Jun;19(6):638-45.

20.

Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics.

Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weinstein MC.

Ann Intern Med. 2000 May 16;132(10):769-79.

PMID:
10819699

Supplemental Content

Support Center